Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (76)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Soler, A. P.
Right arrow Articles by Mullin, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soler, A. P.
Right arrow Articles by Mullin, J. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 8, 1425-1432, August 1999
© 1999 Oxford University Press


Cancer Biology

Increased tight junctional permeability is associated with the development of colon cancer

Alejandro Peralta Soler3, R.Daniel Miller, Kathleen V. Laughlin, Ned Z. Carp1, David M. Klurfeld2 and James M. Mullin

The Lankenau Medical Research Center, 100 Lancaster Avenue, Wynnewood, PA 19096,
1 Department of Surgery, The Lankenau Hospital, Wynnewood, PA and
2 Department of Nutrition and Food Science, Wayne State University, Detroit, MI, USA

Epithelial tissues act as barriers between two fluid compartments, and the epithelial barrier function is provided by the epithelial cells and the tight junctions (TJs) that connect them. We have shown previously that chronic treatment of a cultured epithelial monolayer with phorbol ester tumor promoters induces an increase in transepithelial paracellular permeability and produces tumor-like polyps, suggesting an association between TJ permeability and tumor formation. In this study, we analyzed the association between TJ permeability and formation of tumors in vivo. The permeability of the TJs was assessed in normal human and rat colon epithelia and in colon tumors by measuring the transepithelial electrical resistance, the paracellular flux rate of D-[14C]mannitol and the electron microscopic evaluation of the penetration of the electron dense dye ruthenium red across the TJs. By these criteria, the TJs of human colon tumors, including carcinomas and adenomatous polyps, and the TJs of 1,2-dimethylhydrazine (DMH)-induced rat colon tumors were leakier than the TJs of normal colon. Treatment of rats with the carcinogen DMH induced a progressive increase in the number of aberrant colonic crypts, considered the putative pre-neoplastic colonic phenotype while increasing TJ permeability of the colon epithelium prior to the development of tumors. These results showed that increased TJ permeability of the colon epithelium and consequently a decrease in epithelial barrier function precede the development of colon tumors.

Abbreviations: DMH, 1,2-dimethylhydrazine; EM, Electron microscopy; RR, ruthenium red; Rt, transepithelial electrical resistance; TJ, tight junction

3 To whom correspondence should be addressed Email: solera{at}mlhs.org


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
M. L. Slattery and F.A. Fitzpatrick
Convergence of Hormones, Inflammation, and Energy-Related Factors: A Novel Pathway of Cancer Etiology
Cancer Prevention Research, November 1, 2009; 2(11): 922 - 930.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
X. Yuan, X. Lin, G. Manorek, I. Kanatani, L. H. Cheung, M. G. Rosenblum, and S. B. Howell
Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors
Mol. Cancer Ther., July 1, 2009; 8(7): 1906 - 1915.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Vongsa, N. P. Zimmerman, and M. B. Dwinell
CCR6 Regulation of the Actin Cytoskeleton Orchestrates Human Beta Defensin-2- and CCL20-mediated Restitution of Colonic Epithelial Cells
J. Biol. Chem., April 10, 2009; 284(15): 10034 - 10045.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
Q. HUO, T. KINUGASA, L. WANG, J. HUANG, J. ZHAO, H. SHIBAGUCHI, M. KUROKI, T. TANAKA, Y. YAMASHITA, K. NABESHIMA, et al.
Claudin-1 Protein is a Major Factor Involved in the Tumorigenesis of Colorectal Cancer
Anticancer Res, March 1, 2009; 29(3): 851 - 857.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
N. Shah, S. Khurana, K. Cheng, and J.-P. Raufman
Muscarinic receptors and ligands in cancer
Am J Physiol Cell Physiol, February 1, 2009; 296(2): C221 - C232.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. U. Naik, T. U. Naik, A. T. Suckow, M. K. Duncan, and U. P. Naik
Attenuation of Junctional Adhesion Molecule-A Is a Contributing Factor for Breast Cancer Cell Invasion
Cancer Res., April 1, 2008; 68(7): 2194 - 2203.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. C. Ip, S. T. Cheung, Y. T. Lee, J. C. Ho, and S. T. Fan
Inhibition of hepatocellular carcinoma invasion by suppression of claudin-10 in HLE cells
Mol. Cancer Ther., November 1, 2007; 6(11): 2858 - 2867.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. J. Stewart, J. T. White, X. Yan, S. Collins, C. W. Drescher, N. D. Urban, L. Hood, and B. Lin
Proteins Associated with Cisplatin Resistance in Ovarian Cancer Cells Identified by Quantitative Proteomic Technology and Integrated with mRNA Expression Levels
Mol. Cell. Proteomics, March 1, 2006; 5(3): 433 - 443.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. M. Mullin, J. M. Leatherman, M. C. Valenzano, E. R. Huerta, J. Verrechio, D. M. Smith, K. Snetselaar, M. Liu, M. K. Francis, and C. Sell
Ras Mutation Impairs Epithelial Barrier Function to a Wide Range of Nonelectrolytes
Mol. Biol. Cell, December 1, 2005; 16(12): 5538 - 5550.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. J. Morin
Claudin Proteins in Human Cancer: Promising New Targets for Diagnosis and Therapy
Cancer Res., November 1, 2005; 65(21): 9603 - 9606.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
I. J. Latorre, M. H. Roh, K. K. Frese, R. S. Weiss, B. Margolis, and R. T. Javier
Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells
J. Cell Sci., September 15, 2005; 118(18): 4283 - 4293.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Agarwal, T. D'Souza, and P. J. Morin
Claudin-3 and Claudin-4 Expression in Ovarian Epithelial Cells Enhances Invasion and Is Associated with Increased Matrix Metalloproteinase-2 Activity
Cancer Res., August 15, 2005; 65(16): 7378 - 7385.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Mima, S. Tsutsumi, H. Ushijima, M. Takeda, I. Fukuda, K. Yokomizo, K. Suzuki, K. Sano, T. Nakanishi, W. Tomisato, et al.
Induction of Claudin-4 by Nonsteroidal Anti-inflammatory Drugs and Its Contribution to Their Chemopreventive Effect
Cancer Res., March 1, 2005; 65(5): 1868 - 1876.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. A. Adegboyega, O. Ololade, J. Saada, R. Mifflin, J. F. Di Mari, and D. W. Powell
Subepithelial Myofibroblasts Express Cyclooxygenase-2 in Colorectal Tubular Adenomas
Clin. Cancer Res., September 1, 2004; 10(17): 5870 - 5879.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. L. Kominsky, M. Vali, D. Korz, T. G. Gabig, S. A. Weitzman, P. Argani, and S. Sukumar
Clostridium perfringens Enterotoxin Elicits Rapid and Specific Cytolysis of Breast Carcinoma Cells Mediated through Tight Junction Proteins Claudin 3 and 4
Am. J. Pathol., May 1, 2004; 164(5): 1627 - 1633.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. B. Singh and R. C. Harris
Epidermal Growth Factor Receptor Activation Differentially Regulates Claudin Expression and Enhances Transepithelial Resistance in Madin-Darby Canine Kidney Cells
J. Biol. Chem., January 30, 2004; 279(5): 3543 - 3552.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
J. M. Mullin
Epithelial Barriers, Compartmentation, and Cancer
Sci. Signal., January 20, 2004; 2004(216): pe2 - pe2.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Quan and S.-J. Lu
Identification of genes preferentially expressed in mammary epithelial cells of Copenhagen rat using subtractive hybridization and microarrays
Carcinogenesis, October 1, 2003; 24(10): 1593 - 1599.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. B. A. Rangel, R. Agarwal, T. D'Souza, E. S. Pizer, P. L. Alo, W. D. Lancaster, L. Gregoire, D. R. Schwartz, K. R. Cho, and P. J. Morin
Tight Junction Proteins Claudin-3 and Claudin-4 Are Frequently Overexpressed in Ovarian Cancer but Not in Ovarian Cystadenomas
Clin. Cancer Res., July 1, 2003; 9(7): 2567 - 2575.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
M. F. McEntee, J. M. Cates, and N. Neilsen
Cyclooxygenase-2 Expression in Spontaneous Intestinal Neoplasia of Domestic Dogs
Vet. Pathol., July 1, 2002; 39(4): 428 - 436.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. B. Anderson, K. L. Neufeld, and R. L. White
Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon
PNAS, June 25, 2002; 99(13): 8683 - 8688.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. R. Bruce, A. Giacca, and A. Medline
Possible Mechanisms Relating Diet and Risk of Colon Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1271 - 1279.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.